← Eichor
Study identifier: NCT07120100 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors

Condition: Breast Cancer Female · Gynecologic Cancer  ·  Sponsor: University of Utah

PhaseNA
Planned participants19
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this study is to evaluate the change in pain scores among patients with chemotherapy-induced peripheral neuropathy after receiving treatment with repetitive transcranial magnetic stimulation (rTMS).

This description comes directly from the study's public registry record.

Talk to the study team

Janna Espinosa  ·  801-585-0571  ·  Janna.Espinosa@hci.utah.edu

Newaj Abdullah, MD  ·  801-585-0255  ·  newaj.abdullah@hsc.utah.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Huntsman Cancer Institute at University of UtahSalt Lake City, Utah, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07120100